Metsera is a clinical stage biotechnology firm operating in the obesity field. Metsera's amylin and GLP-1 analogs show promising early weight-loss results, with potential for once-monthly dosing ...

Pine Labs is preparing to raise $1 billion through an IPO, Moneycontrol had exclusively reported earlier. Axis Capital, Morgan Stanley, Citigroup, JP Morgan and Jefferies are running the company ...

Peter Thiel-backed crypto exchange Bullish has confidentially filed for an IPO with the U.S. Securities and Exchange Commission in recent weeks, the Financial Times reported on Tuesday.

Metsera, Inc. (NASDAQ:MTSR) reported encouraging Phase 1 results for MET-233i, its once-monthly amylin analog, which showed a mean weight loss of up to 8.4% at Day 36 after subtracting the placebo.

Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported encouraging Phase 1 results for MET-233i, its once-monthly amylin analog, ...

Metsera is a startup venture established in 2022 that received Series A and B investments just nine months after its official launch and was listed on Nasdaq at the end of January this year.

Following a flurry of activity in early 2025, the IPO scene has cooled in the wake of President Trump’s economic tremors.

The biggest IPO this year barred Americans — and it was a huge success CATL shares soared in Hong Kong debut Last Updated: May 20, 2025 at 8:22 a.m. ET First Published: May 20, 2025 at 3:45 a.m. ET ...

Odyssey first filed for an IPO in January alongside fellow Massachusetts biotech Sionna Therapeutics. The latter company pushed through with its offering, landing on the Nasdaq floor with $219.2 ...

Metsera assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact: Jono Emmett ...

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of ...

Maze is a new type of security platform that uses AI agents to stop cloud security breaches before they happen, starting with an agent for investigating, triaging, and resolving vulnerabilities.